Transient Ischemic Attack News and Research

RSS
A transient ischemic attack (TIA) is a transient stroke that lasts only a few minutes. It occurs when the blood supply to part of the brain is briefly interrupted. TIA symptoms, which usually occur suddenly, are similar to those of stroke but do not last as long. Most symptoms of a TIA disappear within an hour, although they may persist for up to 24 hours. Symptoms can include: numbness or weakness in the face, arm, or leg, especially on one side of the body; confusion or difficulty in talking or understanding speech; trouble seeing in one or both eyes; and difficulty with walking, dizziness, or loss of balance and coordination.
New research suggests tPA can act as neuroprotectant against stroke

New research suggests tPA can act as neuroprotectant against stroke

NMT Medical reports total revenues of $3.0M for first-quarter 2010

NMT Medical reports total revenues of $3.0M for first-quarter 2010

Techniques to protect organs during bypass surgery impair autoregulation, increase risk of stroke: Study

Techniques to protect organs during bypass surgery impair autoregulation, increase risk of stroke: Study

NICE appraisal committee publishes preliminary recommendation of Multaq for AF

NICE appraisal committee publishes preliminary recommendation of Multaq for AF

Cedars-Sinai Neurovascular Center's clinical trial of minimally invasive stenting procedure for TIA

Cedars-Sinai Neurovascular Center's clinical trial of minimally invasive stenting procedure for TIA

TRITON-TIMI 38 study evaluates response rates in patients with common genetic variant in ABCB1 gene

TRITON-TIMI 38 study evaluates response rates in patients with common genetic variant in ABCB1 gene

Two stroke-prevention procedures are equally beneficial for men and women, but effectiveness vary by age

Two stroke-prevention procedures are equally beneficial for men and women, but effectiveness vary by age

Minimally-invasive procedure as effective as gold standard for treating carotid artery blockages: Study

Minimally-invasive procedure as effective as gold standard for treating carotid artery blockages: Study

Overall incidence of stroke, heart attack and death similar in carotid endarterectomy and stenting procedures

Overall incidence of stroke, heart attack and death similar in carotid endarterectomy and stenting procedures

CREST stroke prevention trial: Seminal and robust

CREST stroke prevention trial: Seminal and robust

Dabigatran as effective as warfarin in preventing subsequent strokes among atrial fibrillation patients

Dabigatran as effective as warfarin in preventing subsequent strokes among atrial fibrillation patients

Nearly 40% of TIA and minor ischemic stroke patients may experience mental impairment

Nearly 40% of TIA and minor ischemic stroke patients may experience mental impairment

Acute stroke care and clinical outcomes improve substantially with stroke program

Acute stroke care and clinical outcomes improve substantially with stroke program

NMT Medical completes private placement of common stock and warrants for $5.8M

NMT Medical completes private placement of common stock and warrants for $5.8M

NMT Medical announces preliminary unaudited figures for fiscal 2009

NMT Medical announces preliminary unaudited figures for fiscal 2009

Memory loss or decline in thinking abilities may indicate higher risk of stroke

Memory loss or decline in thinking abilities may indicate higher risk of stroke

Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results

Treatment with Effient more cost effective, show TRITON-TIMI 38 clinical trial results

RRE-90 score: A new web-based tool to predict recurrent stroke risk

RRE-90 score: A new web-based tool to predict recurrent stroke risk

ZYPREXA RELPREVV approved by FDA

ZYPREXA RELPREVV approved by FDA

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment